22.418 articles found

Sort:

Source record

Ziprasidone in the treatment of delayed carbon monoxide encephalopathy.

Hu MC, Shiah IS, Yeh CB, Chen HK, Chen CK.

Prog Neuropsychopharmacol Biol Psychiatry · 2006-03-06

DOI: 10.1016/j.pnpbp.2006.01.019PMID: 16581170

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Inhibition of catechol-O-methyltransferase contributes to more stable levodopa plasma levels.

Müller T, Erdmann C, Muhlack S, Bremen D, Przuntek H, Woitalla D.

Mov Disord · 2006-03-01

DOI: 10.1002/mds.20717PMID: 16211593

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study.

Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, Dujardin M, Grosset DG, Arnold G, Leenders KL, Hundemer HP, Lledó A, Wood A, Frewer P, Schwarz J.

Mov Disord · 2006-03-01

DOI: 10.1002/mds.20724PMID: 16211594

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Placebo-controlled study of rTMS for the treatment of Parkinson's disease.

Lomarev MP, Kanchana S, Bara-Jimenez W, Iyer M, Wassermann EM, Hallett M.

Mov Disord · 2006-03-01

DOI: 10.1002/mds.20713PMID: 16211618

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

RNA knockdown as a potential therapeutic strategy in Parkinson's disease.

Manfredsson FP, Lewin AS, Mandel RJ.

Gene Ther · 2006-03-01

DOI: 10.1038/sj.gt.3302669PMID: 16267570

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease.

Fumagalli F, Racagni G, Riva MA.

Pharmacogenomics J · 2006-03-01

DOI: 10.1038/sj.tpj.6500360PMID: 16402079

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

GDNF in treatment of Parkinson's disease: response to editorial.

Lang AE, Langston JW, Stoessl AJ, Brodsky M, Brooks DJ, Dhawan V, Elias WJ, Lozano AM, Moro E, Nutt JG, Stacy M, Turner D, Wooten GF.

Lancet Neurol · 2006-03-01

DOI: 10.1016/s1474-4422(06)70359-3PMID: 16488373

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

GDNF in treatment of Parkinson's disease: response to editorial.

Penn RD, Dalvi A, Slevin J, Young B, Gash D, Gerhardt G, Hutchinson M.

Lancet Neurol · 2006-03-01

DOI: 10.1016/s1474-4422(06)70360-xPMID: 16488374

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Timing of treatment initiation in Parkinson's disease: a need for reappraisal?

Schapira AH, Obeso J.

Ann Neurol · 2006-03-01

DOI: 10.1002/ana.20789PMID: 16489611

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment should not be initiated too soon in Parkinson's disease.

Aminoff MJ.

Ann Neurol · 2006-03-01

DOI: 10.1002/ana.20814PMID: 16489613

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies.

Bruijn LI, Cudkowicz M.

Expert Rev Neurother · 2006-03-01

DOI: 10.1586/14737175.6.3.417PMID: 16533145

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.

Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC, NET-PD Investigators.

Neurology · 2006-03-01

DOI: 10.1212/01.wnl.0000201251.33253.fbPMID: 16534099

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.